atorvastatin has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castro, AA; De Bem, AF; Mancini, G; Marques, NF; Prediger, RD; Rocha, FL; Santos, ARS; Tasca, CI | 1 |
1 other study(ies) available for atorvastatin and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Atorvastatin; Cytokines; Drug Administration Routes; Drug Administration Schedule; Electron Transport Complex II; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Male; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species | 2018 |